Report on 750 New Medicines in Development for Cancer Released in Baton Rouge

... BATON ROUGE La. April 21 -- ThePharmace... We released this report in Baton Rouge because of its particularrele...The medicines in the report are being tested in human clinical trials... The medicines now in the research pipeline will add to the substantia...

BATON ROUGE, La., April 21 /PRNewswire-USNewswire/ -- The
Pharmaceutical Research and Manufacturers of America (PhRMA) delivered a
new report today on medicines in the research pipeline. The report found
America's pharmaceutical research companies are testing a record 750 new
medicines to help treat cancer.

"We released this report in Baton Rouge because of its particular
relevance to the health of the population in Louisiana," says PhRMA Senior
Vice President Ken Johnson. The report was unveiled at the State Capitol
Building. "According to the Centers for Disease Control and Prevention,
Louisiana has the highest death rate from cancer in the United States. In
fact, recent data from the American Cancer Society tells us that African
American men in Louisiana have the highest death rate and shortest survival
rate in the country for all cancers combined, which is why we are releasing
this report here to coincide with National Cancer Minority Awareness Week."

The medicines in the report are being tested in human clinical trials
or are awaiting approval by the U.S. Food and Drug Administration.

"The medicines now in the research pipeline will add to the substantial
progress made in the last five years by biopharmaceutical companies in
developing new and more effective cancer treatments," notes PhRMA President
and CEO Billy Tauzin. "This strong commitment to research is a product of
the determination of the men and women working for America's pharmaceutical
research companies to develop new medicines that will enable patients to
live longer, healthier, and more productive lives. I am one of those
patients who was diagnosed with cancer and was given a new treatment that
brought me from the brink of death back to life."

Cancer medicines being developed include 113 for lung cancer, the
leading cause of cancer death in the United States; 90 for breast cancer,
which is expected to strike more than 180,000 American women this year; 65
for colorectal cancer, which is the third most common cancer in both men
and women; and 88 for prostate cancer, which this year is expected to kill
28,000 American men. Additional medicines target brain cancer, kidney
cancer, ovarian cancer, pancreatic cancer, skin cancer and others.

The medicines represent many cutting-edge approaches, including one
medicine that targets and kills specific cancer cells, and then activates
the patient's general immune system to destroy any remaining cancer.

"Researchers are making exciting progress in the search for new cures
and treatments for cancer. But these efforts are wasted if the medicines we
develop aren't accessible to patients who need them," says Johnson.

Help is available to patients in need through the Partnership for
Prescription Assistance, a program sponsored by America's pharmaceutical
research companies. To date, the PPA has helped nearly 5 million patients
nationwide, including more than 112,000 people in Louisiana. Since its
launch in April 2005, the PPA bus tour has visited all 50 states and more
than 2,000 cities to educate people about patient assistance programs. The
PPA bus has been to Louisiana seven times since the program was launched.
Just last month, the bus, along with Montel Williams, was in Baton Rouge
for a special event at the Louisiana State Capitol.

The "Help is Here Express" is staffed by trained specialists able to
quickly help uninsured patients in need access information on more than 475
patient assistance programs, including nearly 200 programs offered by
pharmaceutical companies. When the "Help is Here Express" moves on,
patients can visit PPA's easy-to-use Web site (http://www.pparx.org) or call the
toll-free phone number (1-888-4PPA-NOW).

To read the Medicines in Development for Cancer 2008 on the PhRMA web
site, click on the following link: http://www.phrma.org

The Pharmaceutical Research and Manufacturers of America (PhRMA)
represents the country's leading pharmaceutical research and biotechnology
companies, which are devoted to inventing medicines that allow patients to
live longer, healthier, and more productive lives. PhRMA companies are
leading the way in the search for new cures. PhRMA members alone invested
an estimated $44.5 billion in 2007 in discovering and developing new
medicines. Industry-wide research and investment reached a record $58.8
billion in 2007.

(Date:10/4/2017)... Mass. , Oct. 4, 2017 According to the Centers for ... the end of October . PhysicianOne Urgent Care is helping communities across ... Westchester, NY , by offering no-cost* flu shots through the ... as mandated by certain health insurance regulations. ... The best time to get a flu shot is by the ...

(Date:10/2/2017)... 2017 AllianceRx Walgreens Prime, the combined central specialty ... pharmacy benefit manager Prime Therapeutics LLC (Prime), today officially ... the unveiling of new signage at its headquarters in ... at a few other company-owned facilities across the country. ... some of whom will begin to see the AllianceRx ...

(Date:10/13/2017)... ... 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills is proud ... and unique items from across the nation, this holiday-themed event will raise funds and ... the VNA. The boutique will be open Saturday, November 4 (10:00 a.m. – ...

(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... most popular and least understood books in the Holy Scriptures, Revelation. The Book of ... baffled scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl ...

(Date:10/13/2017)... ... ... Journey: From the Mountains to the Mission Field”: the story of a missionary couple ... From the Mountains to the Mission Field” is the creation of published author, Carole ... and currently teaches a class of ladies at her church, which she has taught ...

(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... today the introduction of an innovative new design of the shoulder pad. The ... get maximum comfort while controlling your pain while using cold therapy. By utilizing ice ...